Epikaas (Epirubicin Hydrochloride) is an anthracycline cytotoxic agent used in the treatment of various cancers. It works by interfering with DNA replication in cancer cells, leading to their destruction.

Strengths Available:

• Epikaas 10 mg

• Epikaas 50 mg

Therapeutic Use:

• Breast Cancer

• Ovarian Cancer

• Lung Cancer

• Gastric Cancer

• Bladder Cancer (intravesical use)

Mechanism of Action:
Epirubicin intercalates into DNA strands, inhibiting topoisomerase II and generating free radicals, thereby inducing apoptosis in rapidly dividing cancer cells.

Key Features:

• Manufactured in GMP-certified facilities

• High purity and stability

• Supplied in single-dose vial

• Suitable for intravenous or intravesical administration

• Stringent quality control for safety and efficacy

Packaging:

• Sterile, lyophilized powder in glass vial

• To be reconstituted before use under medical supervision

Storage:

Store 25°C -30°C. Protect from moisture and light. Keep out of reach of children.

Note: For hospital use only. To be administered by qualified healthcare professionals.